UpdatesGeneral Updates
Jagsonpal Pharma acquires 85% of Aequitas Healthcare for 20.8 Cr, strategically entering the hospital segment.
Jagsonpal Pharmaceuticals LimitedJAGSNPHARM · Filed with the exchange
This move leverages Aequitas's established hospital network and 53.31 Cr FY26 revenue, aiming to boost Jagsonpal's market presence and diversify its healthcare business.
No comments yet. Be the first.